Anti-cyclic citrullinated peptide and rheumatoid factor in patients with chronic hepatitis B and hepatitis B carriers.

Dalkiliç, Ediz; Öksüz, Mustafa Ferhat; Tufan, Ayse Nur; Özbek, Aysun; Nizamoglu, Ali; Dolarslan, Mürside Esra; Coskun, Belkis Nihan; Pehlivan, Yavuz

Dalkiliç, Ediz; Öksüz, Mustafa Ferhat; Tufan, Ayse Nur; Özbek, Aysun; Nizamoglu, Ali; Dolarslan, Mürside Esra; Coskun, Belkis Nihan; Pehlivan, Yavuz.

Afiliação

Dalkiliç E; Department of Rheumatology, School of Medicine, University of Uludag, Bursa, Turkey.
Öksüz MF; Department of Rheumatology, School of Medicine, University of Uludag, Bursa, Turkey.
Tufan AN; Department of Rheumatology, School of Medicine, University of Uludag, Bursa, Turkey.
Özbek A; Department of Rheumatology, School of Medicine, University of Uludag, Bursa, Turkey.
Nizamoglu A; Department of Rheumatology, School of Medicine, University of Uludag, Bursa, Turkey.
Dolarslan ME; Department of Rheumatology, School of Medicine, University of Uludag, Bursa, Turkey.
Coskun BN; Department of Rheumatology, School of Medicine, University of Uludag, Bursa, Turkey.
Pehlivan Y; Department of Rheumatology, School of Medicine, University of Uludag, Bursa, Turkey.

Eur J Rheumatol ; 2(2): 62-65, 2015 Jun.

Article em En | MEDLINE | ID: mdl-27708928

Palavras-chave

Hepatitis B; anti-cyclic citrullinated peptide; rheumatoid arthritis; rheumatoid factor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Eur J Rheumatol Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Turquia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google